Discordance between Tuberculin Skin Test and Interferon-gamma Release Assays for Diagnosis of Tuberculosis Infection in Korean Children
Pediatric Infection & Vaccine
;
: 18-24, 2016.
Article
in Korean
| WPRIM
| ID: wpr-87525
ABSTRACT
PURPOSE:
There is a the great diagnostic challenge in pediatric tuberculosis especially in high burden setting. The purpose of this preliminary study is to evaluate the agreement between tuberculin skin test (TST) and interferon-gamma release assay (IGRA) including T-SPOT®-TB and QuantiFERON®-TB Gold (QFT-G) in Korean children.METHOD:
This retrospective study included children and adolescents who visited to Asan Medical Center to evaluate tuberculosis infection using at least two assays of TST, T-SPOT.TB and QFT-G, from January 2014 to April 2015.RESULTS:
A total of 20 patients were included, whose median age was 13.3 years (range, 3.8-18.1 years), and all of them had history of BCG vaccination. Eleven patients had underlying diseases including 7 patients with immunosuppressant medication. The concordance rate between T-SPOT.TB and QFT-G was 90%. However, the concordance rate between TST and T-SPOT.TB was 50%, and between TST and QFT-G was 42.9%. Specificity for the diagnosis of tuberculosis infection of T-SPOT.TB, QFT-G, and TST was 93.3%, 86.7%, and 58.3%, respectively.CONCLUSIONS:
Although there was a discrepancy between TST and IGRA to diagnose tuberculosis, agreement between T-SPOT.TB and QFT-G was relatively high. Further prospective study to validate the clinical usefulness of each assay for immunologic evidence of tuberculosis infection in Korean children will be mandatory.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Skin
/
Tuberculin
/
Tuberculosis
/
Skin Tests
/
Prospective Studies
/
Retrospective Studies
/
Sensitivity and Specificity
/
Interferon-gamma
/
Vaccination
/
Diagnosis
Type of study:
Diagnostic study
/
Observational study
Limits:
Adolescent
/
Child
/
Humans
Language:
Korean
Journal:
Pediatric Infection & Vaccine
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS